Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pioglitazone for Lung Cancer Chemoprevention

NCT00780234 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT00780234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00780234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pioglitazone for Lung Cancer Chemoprevention
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2009
Completion date
August 31, 2017
Enrollment
92 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

endobronchial dysplasia, lung cancer